Exosomes as
Regenerative Treatment
Regenerative Treatment
Exosome Therapy is an innovative regenerative treatment that utilizes the powerful cell-signaling capabilities of exosomes, tiny extracellular vesicles secreted by mesenchymal stem cells (MSCs). These exosomes contain a mix of proteins, enzymes, lipids, and nucleic acids, which are crucial for their therapeutic effects. Exosomes play a significant role in promoting tissue repair, reducing inflammation, and enhancing cellular communication, making them highly effective in treating a variety of medical conditions.
How It Works
Exosomes work by delivering bioactive molecules to damaged or inflamed tissues, stimulating the body’s natural healing processes. They can be administered intravenously for systemic diffusion or directly injected into specific tissues, such as joints or muscles, to target localized issues. Exosomes from MSCs have the unique ability to cross the blood-brain barrier, making them particularly effective for neurological conditions
Therapeutic Benefits
-
Tissue Regeneration
Exosomes promote the repair and regeneration of damaged tissues, including skin, muscle, and organs, by activating progenitor cells and facilitating cellular communication.
-
Anti-inflammatory Effects
They help convert pro-inflammatory cells into anti-inflammatory cells, reducing inflammation and supporting immune regulation.
-
Prevention of Fibrosis
Exosomes regulate the formation of extracellular matrix and collagen, preventing excessive scarring and promoting healthy tissue remodeling.
-
Enhanced Cellular Function
They improve mitochondrial function, reduce oxidative stress, and enhance overall cellular metabolism, aiding in the recovery from inflammatory and ischemic conditions.
Citations and Scientific References
CKM Stem Cells sources exosomes from placental-derived mesenchymal stem cells, ensuring high potency and efficacy. These exosomes are ethically collected and processed under strict regulatory standards to guarantee safety and quality. They do not provoke an immune response and are free from the risk of malignant transformation.
Experience the advanced healing potential of exosome therapy at CKM Stem Cells. Contact us today to schedule a consultation and discover how our innovative regenerative treatments can enhance your health and well-being.
Citations
VIEW CITATIONS
-
Földes, A., Kádár, K., Kerémi, B., Zsembery, Á., Gyires, K., S Zádori, Z., & Varga, G. (2016). Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage. Current neuropharmacology, 14(8), 914–934. https://www.eurekaselect.com/article/73157
-
Zheng H, Zhang B, Chhatbar PY, Dong Y, Alawieh A, Lowe F, Hu X, Feng W. Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research. Cell Transplant. 2018 Dec;27(12):1723-1730. https://pubmed.ncbi.nlm.nih.gov/30343609/.
-
Schepici G, Silvestro S, Bramanti P, Mazzon E. Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches. Medicina (Kaunas). 2020 Mar 19;56(3):137. https://pubmed.ncbi.nlm.nih.gov/32204311/.
-
Rahman MM, Islam MR, Islam MT, Harun-Or-Rashid M, Islam M, Abdullah S, et al. Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives. Biology. 2022; 11(1):147. https://doi.org/10.3390/biology11010147
-
Kassis I, Petrou P, Vaknin-Dembinsky A, Karussis D. Mesenchymal stem cells in neurological diseases. Clin. Invest. https://pmc.ncbi.nlm.nih.gov/articles/PMC8024997/.
-
Chung JW, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim SK, Lee JS, Sohn SI, Kim YH; STARTING-2 Collaborators. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. 2021 Feb 16;96(7):e1012-e1023. Available from: https://doi.org/10.1212/WNL.0000000000011440
-
Sun, J. M., Dawson, G., Franz, L., Howard, J., McLaughlin, C., Kistler, B., Waters-Pick, B., Meadows, N., Troy, J., & Kurtzberg, J. Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder. Stem cells translational medicine.2020:9(10):1137–1146. Available from: https://doi.org/10.1002/sctm.19-0434
-
